|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
08037 CH BIOTECH SER
Nominal 
0.610 -0.005 (-0.813%) | 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/06 HKD(K$) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | |
| Turnover | 37,226 | -4.234% | 38,872 | 32,449 | 182,357 | 686,909 |
| Cost of Sales | (32,037) | -11.817% | (36,330) | (35,556) | (121,031) | (332,005) |
| Gross Profit | 5,189 | 104.131% | 2,542 | (3,107) | 61,326 | 354,904 |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/06 HKD(K$) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 84,233 | -- | (5,315) | 3,016 | 14,854 | 2,690 | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | 1,696 | |
| Other Non-operating Items | -- | -- | -- | -- | (26) | (1,527) | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | (2,771) | (1,032) | |
| Profit / (Loss) before Taxation | 26,146 | -- | (37,159) | (126,258) | (24,677) | 253,756 | |
| Taxation | 610 | 50.246% | 406 | 527 | (3,044) | (47,396) | |
| Profit / (Loss) from Discontinued Operations | (11,697) | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 3,171 | -33.200% | 4,747 | 45,814 | (2,763) | (138,140) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 18,230 | -- | (32,006) | (79,917) | (30,484) | 68,220 | |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/06 HKD(K$) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | |
| Net Finance Costs / (Income) | 26,766 | 113.701% | 12,525 | 4,245 | 1,026 | 2,294 |
| Depreciation & Amortisation | 16,854 | 130.340% | 7,317 | 12,904 | 35,346 | 33,341 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| EPS (cts) | 1.900 | -- | -3.300 | -8.300 | -3.200 | 7.100 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 0.222 | -- | 0.245 | 0.405 | 0.565 | 0.443 |
| Remarks: | Real time quote last updated: 11/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 18,230 |
| %Change | -- |
| EPS / (LPS) | HKD 0.019 |
| NBV Per Share ($) | HKD 0.222 |